{
    "organizations": [],
    "uuid": "9e29668a5dcd7854cfb87e903e761298d34b8ca8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-la-jolla-pharmaceutical-quarterly/brief-la-jolla-pharmaceutical-quarterly-loss-per-share-2-22-idUSASC0A1NP",
    "ord_in_thread": 0,
    "title": "BRIEF-La Jolla Pharmaceutical Quarterly Loss Per Share $2.22",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - La Jolla Pharmaceutical Co:\n* LA JOLLA PHARMACEUTICAL ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018 AND RECENT CORPORATE PROGRESS\n* QUARTERLY LOSS PER SHARE $2.22 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-11T04:50:00.000+03:00",
    "crawled": "2018-05-11T12:47:28.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "la",
        "jolla",
        "pharmaceutical",
        "co",
        "la",
        "jolla",
        "pharmaceutical",
        "announces",
        "financial",
        "result",
        "three",
        "month",
        "ended",
        "march",
        "recent",
        "corporate",
        "progress",
        "quarterly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}